Fullerton, CANCT06655441Now EnrollingIRB Ready

Dry Eye Disease (DED) Clinical Trial in Fullerton, CA

Access cutting-edge dry eye disease (ded) treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.

Sponsored by Southern California College of Optometry at Marshall B. Ketchum University

Quick Self-Assessment

See if you qualify for this Fullerton location

Preparing your pre-screening questions…

Expert Care in Fullerton

Access dry eye disease (ded) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye disease (ded) treatment provided free

Apply for This Fullerton Location

Check if you qualify for this dry eye disease (ded) clinical trial in Fullerton, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fullerton

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fullerton site if eligible
  4. 4Begin participation

About This Dry Eye Disease (DED) Study in Fullerton

The purpose of this research study is to evaluate the effects of trehalose, an ingredient found in commercially available artificial tears, on the corneal barrier function. The investigators will assess corneal dryness and measure the relative corneal epithelial "barrier" function (the degree to which the cornea can prevent penetration of sodium fluorescein dye into the eye) after using eye drops that contain 3% trehalose for one month.

Sponsor: Southern California College of Optometry at Marshall B. Ketchum University

Who Can Participate

Inclusion Criteria

Adult subjects, \> age 18 years, with moderate-to-severe dry eye, defined as fitting criteria for dry eye stages 3 or 4 of the MGD Workshop Management and Treatment subcommittee report.
Subjects must have normal eyelid position and closure.
For enrollment as aqueous tear deficiency, subjects must have a Schirmer I result of \< 5.0 mm wetting in 5 minutes without anesthesia.

Exclusion Criteria

History or evidence of ocular or intraocular surgery in either eye within the past twelve months. LASIK and other kerato-refractive procedure patients can qualify if the most recent surgery or enhancement was 12 or more months prior.
History or evidence of serious ocular trauma in either eye within the past six months.
History of hypersensitivity to any component of the study medications.
History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia, active or recent varicella, viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva; mycobacterial infection of the eye; and/or fungal disease of the eye.
History or evidence of active ocular allergy.
Females who are pregnant, nursing, or planning a pregnancy during the study.
Evidence of greater than mild eyelid deformity (e.g., ectropion, entropion, ptosis).
Use of concomitant topical ocular medications during the study duration.
Individuals using systemic steroids, immunosuppressive agents and/or anti-cholinergic (e.g. cold and allergy medications, tricyclic antidepressants) for treatment of autoimmune connective tissue disease may not be enrolled in the study if they have not been on a stable dosing regimen for a minimum of 30 days prior to the visit.
Individuals with uncontrolled diabetes or history or evidence of peripheral neuropathy.
Active intraocular inflammatory conditions such as iritis.
Individuals wearing rigid gas permeable or scleral contact lenses within the previous six months of enrollment. Subjects can have worn soft lenses, but not within one month prior to enrollment.
Individuals using punctual plugs inserted within 30 days of study start.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fullerton?

Yes, this clinical trial (NCT06655441) has an active research site in Fullerton, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Disease (DED) Treatment Options in Fullerton, CA

If you're searching for dry eye disease (ded) treatment options in Fullerton, CA, this clinical trial (NCT06655441) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry eye disease (ded) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye disease (ded) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Fullerton, CA

See all ankylosing spondylitis clinical trials recruiting in Fullerton — not just this study.

Browse Ankylosing Spondylitis Trials in Fullerton

Ready to Join in Fullerton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fullerton, CA